BOX:F:F-Becton Dickinson and Company (EUR)

COMMON STOCK | Medical Instruments & Supplies |

Last Closing

USD 156.1

Change

+2.85 (+1.86)%

Market Cap

USD 43.29B

Volume

45.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-29 )

Largest Industry Peers for Medical Instruments & Supplies

Symbol Name Price(Change) Market Cap
IUI1:F Intuitive Surgical Inc

-0.75 (-0.15%)

USD 180.46B
ESL:F EssilorLuxottica Société ano..

-4.00 (-1.60%)

USD 118.76B
ESLC:F ESSILORLUXOTTICA 1/2/O.N.

-3.00 (-2.42%)

USD 115.21B
HYB0:F HOYA CORP. ADR/ 1 O.N.

-4.00 (-3.77%)

USD 37.66B
HYB:F HOYA Corporation

-2.35 (-2.19%)

USD 37.63B
RME:F ResMed Inc

+0.10 (+0.05%)

USD 32.97B
RMEA:F Resmed Inc DRC

-0.20 (-0.93%)

USD 31.15B
CBH:F COLOPLAST SP.ADR 1/10 DK1

+0.05 (+0.60%)

USD 21.20B
56S0:F RENAU.UNSP.ARD 1/5 EO-20

-0.20 (-1.06%)

USD 20.06B
56S1:F Sartorius Stedim Biotech SA

-2.30 (-1.19%)

USD 19.82B

ETFs Containing BOX:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Instruments & Supplies) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -28.13% 15% F 14% F
Dividend Return 0.44% 32% F 12% F
Total Return -27.69% 15% F 13% F
Trailing 12 Months  
Capital Gain -24.77% 23% F 25% F
Dividend Return 1.88% 43% F 21% F
Total Return -22.89% 25% F 23% F
Trailing 5 Years  
Capital Gain -27.63% 43% F 21% F
Dividend Return 8.26% 52% F 13% F
Total Return -19.37% 37% F 16% F
Average Annual (5 Year Horizon)  
Capital Gain 0.72% 52% F 43% F
Dividend Return 1.65% 51% F 39% F
Total Return 0.93% 49% F 27% F
Risk Return Profile  
Volatility (Standard Deviation) 10.20% 99% N/A 91% A-
Risk Adjusted Return 16.20% 57% F 44% F
Market Capitalization 43.29B 97% N/A 95% A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector